Literature DB >> 11277324

Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer.

D Cappelletti1, A Cardillo, E Bonanno, S P Prete, G Cucchiara, M Turriziani, J W Greiner, A Cottarelli, E Breda, A Aquino, E Bonmassar, L De Vecchis.   

Abstract

Treatment with 5-fluorouracil (5-FU) or recombinant interferon-gamma (IFN), alone or in combination, was found to increase carcinoembryonic antigen (CEA) expression in several carcinoma cell lines. In this study we examined the in vitro effect of these agents on CEA expression of tumor cells, obtained from a patient operated for rectal cancer. The results showed that exposure of cancer cells to 5-FU or to IFN resulted in increased CEA levels in terms of percentage of CEA-positive cells and mean fluorescence values, as indicated by FACS analysis. However, drug combination did not induce CEA expression higher than that provided by single agents alone. Treatment with 5-FU or with IFN produced a reduction of the total number of viable cells. Moreover, Western blot analysis revealed that exposure of cancer cells to each drug was followed by a substantial increase of the total cellular CEA content. On the contrary, 5-FU in combination with IFN did not increase the expression of the antigen more than that obtained by single agents. Noteworthy, exposure of CEA-negative cells from adjacent normal rectal tissue to both agents alone or in combination, did not result in CEA induction. In conclusion, the present results suggest new approaches aimed at (a) increasing the sensitivity of diagnostic procedures based on detection of CEA-positive tumor cells; (b) facilitating the recognition of CEA-positive cancer cells by immune responses induced by anti-CEA peptide vaccines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11277324

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.

Authors:  Ebrahim Eftekhar; Fakhraddin Naghibalhossaini
Journal:  Mol Biol Rep       Date:  2013-11-29       Impact factor: 2.316

2.  Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs.

Authors:  Shunroh Ohtsukasa; Satoshi Okabe; Hironori Yamashita; Takehisa Iwai; Kenichi Sugihara
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-15       Impact factor: 4.553

3.  Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy.

Authors:  Salvatore P Prete; Mario Turriziani; Maria C Massara; Alessia De Rossi; Pierpaolo Correale; Liana De Vecchis; Francesco Torino; Laura Bonmassar; Angelo Aquino
Journal:  J Exp Clin Cancer Res       Date:  2008-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.